Chemomab Therapeutics Ltd.
CMMB · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 13, 2026 | — | — | — | -0.04 | — |
| 2026 Q1 | May 14, 2026 | — | — | -0.22 | -0.04 | — |
| 2025 Q4 | March 19, 2026 | — | — | -0.24 | -0.20 | -6.55% |
| 2025 Q3 | November 21, 2025 | — | — | 0.32 | — | — |
| 2025 Q2 | August 13, 2025 | — | — | -0.36 | -0.80 | — |
| 2025 Q1 | May 15, 2025 | — | — | -0.56 | -0.80 | +6.20% |
| 2024 Q4 | March 3, 2025 | — | — | -0.64 | -0.80 | -15.54% |
| 2024 Q3 | November 14, 2024 | — | — | -0.80 | -0.80 | 0.00% |
| 2024 Q2 | August 21, 2024 | — | — | -1.04 | -0.80 | -1.61% |
| 2024 Q1 | May 9, 2024 | — | — | -1.12 | -0.80 | +11.72% |
| 2023 Q4 | March 7, 2024 | — | — | -1.04 | -1.60 | +12.63% |
| 2023 Q3 | November 9, 2023 | — | — | -1.36 | -2.40 | -6.10% |
| 2023 Q2 | August 14, 2023 | — | — | -2.88 | -3.20 | -4.24% |
| 2023 Q1 | May 11, 2023 | — | — | -3.20 | -3.20 | -1.52% |
| 2022 Q4 | March 20, 2023 | — | — | -0.72 | -0.80 | — |
| 2022 Q3 | November 11, 2022 | — | — | -2.80 | -2.40 | 0.00% |